PREMIUM
Health
Ugandan scientists welcome twice-yearly injection against HIV
"After over a decade of working on HIV PrEP trials, it's extremely fulfilling to get such amazing results from the PURPOSE1 study,” said Dr Flavia Matovu Kiweewa.
Dr Flavia Matovu Kiwewa and Linda-Gail Bekker, the director of the Desmond Tutu HIV Center at the University of Cape Town welcomed the new study. Courtesy photo
By: NewVision Reporter, Journalists @NewVision
A groundbreaking research done in Uganda and South Africa has shown that Lenacapavir, an injectable drug administered once in six months to prevent HIV infection, is 100% effective